| 1. |
Ray K, Chaki M, Sengupta M. Tyrosinase and ocular diseases: some novel thoughts on the molecular basis of oculocutaneous albinism type 1[J]. Prog Retin Eye Res, 2007, 26(4): 323-358. DOI: 10.1016/j.preteyeres.2007.01.001.
|
| 2. |
Summers CG. Albinism: classification, clinical characteristics, and recent findings[J]. Optom Vis Sci, 2009, 86(6): 659-662. DOI: 10.1097/OPX.0b013e3181a5254c.
|
| 3. |
Khanal S, Pokharel A, Kandel H. Visual deficits in Nepalese patients with oculocutaneous albinism[J]. J Optom, 2016, 9(2): 102-109. DOI: 10.1016/j.optom.2015.01.002.
|
| 4. |
Hu DN, John DS, Tadeusz S. Role of ocular melanin in ophthalmic physiology and pathology[J]. Photochem Photobiol, 2008, 84(3): 639-644. DOI: 10.1111/j.1751-1097.2008.00316.x.
|
| 5. |
Autrata R, Senková K, Holousová M, et al. Combined treatment with laser photocoagulation and cryotherapy for threshold retinopathy of prematurity[J]. Eur J Ophthalmol, 2008, 18(1): 112-117.
|
